文献速递心力衰竭与心肌病

体力活动与射血分数保留心衰患者预后:TOPCAT试验分析

Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
PubMed 文献 · Circulation · 2017-06-21

本研究基于TOPCAT试验美洲区1751例射血分数保留心衰患者,按美国心脏协会标准将基线自报体力活动分为差、中等和理想三级。中位随访2.4年发现,与理想活动者相比,差和中等活动者主要复合终点、心衰住院及心血管死亡风险均显著升高。

要点

  • 仅11%患者达到理想体力活动水平,75%为差水平。
  • 差和中等体力活动者主要复合终点风险分别升高约2倍。
  • 体力活动差与心血管死亡风险升高约4倍相关。

核心结论

  • 在射血分数保留心衰患者中,差和中等自报体力活动均与较高的心衰住院和死亡风险相关。

研究设计与样本

  • TOPCAT试验美洲区1751例患者的基线自报体力活动分析,按AHA标准分为差、中等、理想三级,采用多变量Cox模型。

主要发现

  • 平均年龄68.6±9.6岁,理想活动11%、中等14%、差75%。
  • 中位随访2.4年,主要复合终点发生519例(心衰住院397、心血管死亡222、中止性心脏骤停6)。
  • 与理想活动相比,差活动主要复合终点HR 2.05(95%CI 1.28-3.28),中等活动HR 1.95(95%CI 1.15-3.33)。
  • 差活动心衰住院HR 1.93(95%CI 1.16-3.22),心血管死亡HR 4.36(95%CI 1.37-13.83)。
  • 中等活动心衰住院HR 1.84(95%CI 1.02-3.31),心血管死亡HR 4.05(95%CI 1.17-14.04)。

临床怎么用

  • 对射血分数保留心衰患者应评估体力活动水平,低活动者可能需加强干预和随访。

局限性

  • 体力活动为基线自报,可能存在回忆偏倚和错分;研究为观察性分析,不能确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Physical activity (PA) is inversely associated with adverse cardiovascular outcomes in healthy populations, but the impact of physical activity in patients with heart failure (HF) with preserved ejection fraction is less well characterized. METHODS: The baseline self-reported PA of 1751 subjects enrolled in the Americas region of the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) was categorized as poor, intermediate, or ideal PA with American Heart Association criteria. PA was related to the primary composite outcome (HF hospitalization, cardiovascular mortality, or aborted cardiac arrest), its components, and all-cause mortality with the use of multivariable Cox models. RESULTS: The mean age at enrollment was 68.6±9.6 years. Few patients met American Heart Association criteria for ideal activity (11% ideal, 14% intermediate, 75% poor). Over a median follow-up of 2.4 years, the primary composite outcome occurred in 519 patients (397 HF hospitalizations, 222 cardiovascular deaths, and 6 aborted cardiac arrests). Compared with those with ideal baseline PA, poor and intermediate baseline PA was associated with a greater risk of the primary outcome (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.28-3.28; HR, 1.95; 95% CI, 1.15-3.33, respectively), HF hospitalization (HR, 1.93; 95% CI, 1.16-3.22; HR, 1.84; 95% CI, 1.02-3.31), cardiovascular mortality (HR, 4.36; 95% CI, 1.37-13.83; HR, 4.05; 95% CI, 1.17-14.04), and all-cause mortality (HR, 2.95; 95% CI, 1.44-6.02; HR, 2.05; 95% CI, 0.90-4.67) after multivariable adjustment for potential confounders. CONCLUSIONS: In patients with HF with preserved ejection fraction, both poor and intermediate self-reported PA were associated with higher risk of HF hospitalization and mortality. CLINICAL TRIAL REGISTRATION: URL: https://clinicaltrials.gov. Unique identifier: NCT00094302.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Hegde SM, Claggett B, Shah AM, et al. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist). Circulation. 2017. PMID: 28637881. doi:10.1161/CIRCULATIONAHA.117.028002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。